Multiple signaling pathways were also involved in the pharmacological mechanisms of magnolol against cancer, such as PI3K/Akt/mTOR signaling, MAPK signaling and NF-κB signaling (Table 1 and Figure 2). This evidence concerns the gene NFKB1 and cancer.